Friday, March 14, 2008 8:21:59 AM
or both may be liquidating some of the rprx shares due to KERYX hit.
****************Well lets compare the two. One is a specialty healthcare hedge fund/private equity shop who has a slew of positions down 30-50%+ for the year and a bunch of "faster money" fund of fund investors. One the other hand is a monstrous sized mutual fund who could absorb one bad stock move and who was adding last time they filed. Hmmmm.
If you look at a lot of GP's positions over the last 2 wks, many were down 20% which smelled of a large holder getting out. My guess (this is qualified as a guess) is that they are experiencing a good amount of redemptions, if not in serious trouble. This is an opinion based on nothing more than performance of many of their names in the past months, the type of investors they have and the sharp drop in many of their stocks over the last few weeks- I do not know for sure though.
I believe whoever the seller is that he/she is not cleaned up. The 250-300k of blocks over the last few days were at the tail end of a significant quantity of shares being leaked out of the prior 3 weeks (there was a lot of leaking- those days that the stock closed positive by a cent or two and someone joked about manipulation- that was some persons buying everything anyone would give them at a flat to down stock price).
Recent RPRX News
- Royalty Pharma Announces Inaugural Prize for Impact in Healthcare • GlobeNewswire Inc. • 11/14/2024 09:30:00 PM
- Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million • GlobeNewswire Inc. • 11/07/2024 12:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2024 02:24:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 12:35:00 PM
- Royalty Pharma Reports Third Quarter 2024 Results • GlobeNewswire Inc. • 11/06/2024 12:15:00 PM
- Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo • GlobeNewswire Inc. • 11/04/2024 09:15:00 PM
- Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™ • PR Newswire (US) • 11/04/2024 09:01:00 PM
- Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024 • GlobeNewswire Inc. • 10/16/2024 08:15:00 PM
- Royalty Pharma Declares Fourth Quarter 2024 Dividend • GlobeNewswire Inc. • 10/11/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 12:39:00 PM
- Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement • GlobeNewswire Inc. • 09/03/2024 09:14:32 PM
- Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement • GlobeNewswire Inc. • 09/03/2024 09:06:29 PM
- Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference • GlobeNewswire Inc. • 08/28/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 11:20:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 11:19:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 11:17:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 01:02:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:20:53 AM
- Royalty Pharma Reports Second Quarter 2024 Results • GlobeNewswire Inc. • 08/08/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 11:04:01 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 07/29/2024 08:30:11 PM
- Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital • GlobeNewswire Inc. • 07/24/2024 12:30:00 PM
- Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024 • GlobeNewswire Inc. • 07/19/2024 12:15:00 PM
- Royalty Pharma Declares Third Quarter 2024 Dividend • GlobeNewswire Inc. • 07/17/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 12:03:31 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM